Saghar Bagheri MD
Retinal Disease
Harvard-trained Eye Doctor & Medical Retina Fellow at UCLA
Join to View Full Profile
UCLA Health300 UCLA Medical PlazaLos Angeles, CA 90095
Dr. Bagheri is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Saghar Bagheri is a Harvard-trained ophthalmologist based in Los Angeles, CA specializing in retinal diseases.
Her educational background includes a PhD in Clinical Pharmacology, a post-doctoral fellowship in Inherited Retinal Diseases at Johns Hopkins Hospital and a post-doctoral fellowship in Retinal Diseases at Harvard Medical School.
Education & Training
University of California, Los AngelesFellowship, Medical Retina, 2025 - 2026
Mass General Brigham/Massachusetts Eye and Ear/Harvard Medical SchoolResidency, Ophthalmology, 2021 - 2025
Mass General Brigham/Newton-Wellesley HospitalInternship, Transitional Year, 2020 - 2021- Massachusetts Eye and Ear, HarvardFellowship, 2016 - 2020
- Johns Hopkins HospitalFellowship, 2015 - 2016
Univ Dusseldorf- Med AcadClass of 2014
Certifications & Licensure
CA State Medical License 2025 - 2027
MA State Medical License 2020 - 2025
Awards, Honors, & Recognition
- AMD Breakthrough Award 2020 $300,000
- AMD Breakthrough Award 2022 $150,000
Publications & Presentations
PubMed
- Sterile Intraocular Inflammation Following Intravitreal Injections: Pathogenesis, Clinical Features, and Management.Saghar Bagheri, Dimitrios P Ntentakis, Maria Emfietzoglou, Helia Ashourizadeh, Nicole Grinspan
International Ophthalmology Clinics. 2025-07-01 - 1 citationsCost-effectiveness Analysis of Digital Therapeutics for Amblyopia.Irene Koc, Saghar Bagheri, Rachel K Chau, Sandra Hoyek, Nour Abou Shousha
Ophthalmology. 2025-06-01 - 24 citationsNonresponders to Ranibizumab Anti-VEGF Treatment Are Actually Short-term Responders: A Prospective Spectral-Domain OCT Study.Georgios Bontzos, Saghar Bagheri, Larissa Ioanidi, Ivana K. Kim, Ioannis Datseris
Ophthalmology. Retina. 2020-12-01
Press Mentions
Interview with the French Journal of OphthalmologyDecember 26th, 2020
Interview with the Macular Degeneration FoundationDecember 26th, 2020
List of nation‘s top vision scientistsDecember 26th, 2020- Join now to see all
Grant Support
- AMD Breakthrough Award $150,000Foundation2022–2024
- AMD Breakthrough Award $300,000Foundation2020–2022
- German Research Foundation (DFG) ScholarshipGerman Research Foundation (DFG)Present
Committees
- Resident Representative, Executive Committee, American Society of Ophthalmic Trauma (ASOT) 2021 - Present
- Class Representative, Wellness Committee, Harvard Ophthalmology Residency Program 2021 - Present
Professional Memberships
- Member
- ARVOMember
- NEOSMember
- Women in OphthalmologyMember
Other Languages
- German, Farsi, French
External Links
- Harvard Catalyst Profilehttps://connects.catalyst.harvard.edu/Profiles/display/Person/153286
- Google Scholar https://scholar.google.com/citations?user=CI84KJwAAAAJ&hl=en
- ScEYEnce Top Vision Scientistshttps://sceyence.org/top-scientists/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
